Pancreatic Cancer and the Promise of Personalized Medicine
DOI:
https://doi.org/10.47611/jsr.v12i2.1920Keywords:
Cancer, Pancreatic Cancer, Cancer Treatment, Personalized MedicineAbstract
Pancreatic cancer, among which pancreatic ductal adenocarcinoma (PDAC) is the most common type, has a nearly identical incidence to mortality rate. Difficulties in early detection, diagnosis, and treatment are primarily responsible, all of which are further complicated by the molecular biology and etiology of the disease. To succeed in improving treatment options and survival rates, a deeper understanding of pancreatic cancer pathogenesis, as well as the pathogenesis of individual patients, is crucial. This is where personalized medicine comes into play, as it allows for a more specific diagnosis and choice of treatment that utilizes the genetic and cellular makeup of an individual’s cancer cells to provide a basis for the diagnosis and treatment. Personalized medicine is a rapidly growing field that shows promise in overcoming challenges in treating pancreatic cancer, all of which are explored in this article.
Downloads
Metrics
References or Bibliography
Key statistics for pancreatic cancer. American Cancer Society. (n.d.). Retrieved February 24, 2023, from https://www.cancer.org/cancer/pancreatic-cancer/about/key-statistics.html.
Ilic, M., & Ilic, I. (2016). Epidemiology of pancreatic cancer. World journal of gastroenterology, 22(44), 9694–9705. https://doi.org/10.3748/wjg.v22.i44.9694
Park, W., Chawla, A., & O'Reilly, E. M. (2021). Pancreatic Cancer: A Review. JAMA, 326(9), 851–862. https://doi.org/10.1001/jama.2021.13027.
Can pancreatic cancer be found early? American Cancer Society. (n.d.). Retrieved February 25, 2023, from https://www.cancer.org/cancer/pancreatic-cancer/detection-diagnosis-staging/detection.html.
Zhang, L., Sanagapalli, S., & Stoita, A. (2018). Challenges in diagnosis of pancreatic cancer. World journal of gastroenterology, 24(19), 2047–2060. https://doi.org/10.3748/wjg.v24.i19.2047.
Grant, T. J., Hua, K., & Singh, A. (2016). Molecular Pathogenesis of Pancreatic Cancer. Progress in molecular biology and translational science, 144, 241–275. https://doi.org/10.1016/bs.pmbts.2016.09.008.
Hu, J. X., Zhao, C. F., Chen, W. B., Liu, Q. C., Li, Q. W., Lin, Y. Y., & Gao, F. (2021). Pancreatic cancer: A review of epidemiology, trend, and risk factors. World journal of gastroenterology, 27(27), 4298–4321. https://doi.org/10.3748/wjg.v27.i27.4298.
Can pancreatic cancer be found early? American Cancer Society. (n.d.). Retrieved February 25, 2023, from https://www.cancer.org/cancer/pancreatic-cancer/detection-diagnosis-staging/detection.html.
National Cancer Institute. (n.d.). Germline Variant. NCI Dictionary of Genetics terms. Retrieved February 24, 2023, from https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/germline-variant.
National Cancer Institute. (n.d.). The genetics of cancer. National Cancer Institute. Retrieved February 27, 2023, from https://www.cancer.gov/about-cancer/causes-prevention/genetics#is-cancer-hereditary.
National Cancer Institute. (n.d.). Somatic mutation. NCI Dictionary of Cancer terms. Retrieved February 24, 2023, from https://www.cancer.gov/publications/dictionaries/cancer-terms/def/somatic-mutation.
National Cancer Institute. (n.d.). KRAS gene. NCI Dictionary of Cancer terms. Retrieved February 24, 2023, from https://www.cancer.gov/publications/dictionaries/cancer-terms/def/kras-gene.
National Cancer Institute. (n.d.). Tumor microenvironment. NCI Dictionary of Cancer terms. Retrieved February 24, 2023, from https://www.cancer.gov/publications/dictionaries/cancer-terms/def/tumor-microenvironment.
Opitz, F. V., Haeberle, L., Daum, A., & Esposito, I. (2021). Tumor Microenvironment in Pancreatic Intraepithelial Neoplasia. Cancers, 13(24), 6188. https://doi.org/10.3390/cancers13246188.
Beatty, G. L., Werba, G., Lyssiotis, C. A., & Simeone, D. M. (2021). The biological underpinnings of therapeutic resistance in pancreatic cancer. Genes & development, 35(13-14), 940–962. https://doi.org/10.1101/gad.348523.121.
McGuigan, A., Kelly, P., Turkington, R. C., Jones, C., Coleman, H. G., & McCain, R. S. (2018). Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes. World journal of gastroenterology, 24(43), 4846–4861. https://doi.org/10.3748/wjg.v24.i43.4846.
Luo J. (2021). KRAS mutation in pancreatic cancer. Seminars in oncology, 48(1), 10–18. https://doi.org/10.1053/j.seminoncol.2021.02.003.
Cao, D., Song, Q., Li, J., Jiang, Y., Wang, Z., & Lu, S. (2021). Opportunities and challenges in targeted therapy and immunotherapy for pancreatic cancer. Expert reviews in molecular medicine, 23, e21. https://doi.org/10.1017/erm.2021.26.
Published
How to Cite
Issue
Section
Copyright (c) 2023 Lucas Kim; YuJin Lee
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright holder(s) granted JSR a perpetual, non-exclusive license to distriute & display this article.
